Trial intelligence / Profile preview

Influvac vaccination responses in rheumatoid arthritis patients treated with rituximab

NL-OMON25369Recruiting

Sponsor
University Medical Center Groningen
Start
Oct 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of influenza vaccine in influenza (5 arms), sponsored by University Medical Center Groningen. Primary endpoints: Humoral immune response after vaccination and Cellular immune response after vaccination. Started Oct 2007; status: recruiting.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON25369.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25369.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call